TRAJ : Transition in Rheumatology, From Adolescence to Adulthood
ConditionTransitional Care
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
This study evaluates the impact of the CAPAdJA transition support program on care continuity for young patients with chronic rheumatic diseases at Bordeaux University Hospital. The primary objective is to compare the proportion of patients lost to follow-up six months after the transition consultation between those who benefited from CAPAdJA and those who did not.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who benefited from a pediatric-to-adult rheumatology transition consultation at Bordeaux University Hospital between 2017 and 2024
Patients over 18 years old at the time of completing the self-administered questionnaire.
Disqualifiers
Patients who do not speak French
Patients who have refused to participating
Trial design
Design model
Single group
Treatments tested in this trial
Self-questionnaire : satisfaction and quality of life
Other interventionPatient satisfaction and quality of life outcomes assessed through standardized self-reported questionnaires completed day of inclusion (6 months after the pediatric-to-adult rheumatology transition consultation realized in the context of programm CAPADJA or not. )
Self-reported questionnaire : educational or professional
Other interventionPatient educational or professional outcomes, assessed through standardized self-reported questionnaires completed day of inclusion (6 months after the pediatric-to-adult rheumatology transition consultation realized in the context of programm CAPADJA or not. )
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: CAPAdJA group and Non-CAPADJA groupOther 2 interventions
Trial outcomes
Primary outcomes
1
Follow-up patient
The primary endpoint is the proportion of patients lost to follow-up 6 months after the transition consultation, considered to be an indicator of continuity of care and, by extension, of the medical success of the transition. This criterion will be evaluated by examining the presence or absence of follow-up consultations in the adult rheumatology department, as recorded in the CHU consultation software, six months after the transition appointment.
Time frame
six months after the transition appointmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: